The use of an automated external defibrillator, or AED, can save lives in cases of sudden cardiac arrest. It is a simple-to-use medical gadget that can assess the heart’s rhythm and, if necessary, shock the heart with electricity to help it regain a healthy rhythm. One can be revived from a sudden cardiac arrest with an AED. This generally happens when there is an interruption in the electrical activity of the heart, which results in a pulse that is either dangerously rapid or fast and irregular. A fundamental and essential part of treating sudden cardiac arrest is defibrillation. The use of AEDs is common when someone has a sudden cardiac arrest.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/5078
By the end of 2022, the market for automated external defibrillators is anticipated to be worth US$ 773.3 million.
The global market for automated external defibrillators is predicted to develop at a faster rate than average over the forecast period as a result of increased AED usage due to the rising incidence of sudden cardiac arrests throughout the world. For instance, approximately 356,000 cardiac arrests occur outside of hospitals each year in the United States, and over 90% of them result in death, according to the American Heart Association. Additionally, according to the Canadian Centre for Occupational Health and Safety’s (CCOHS) June 2020 report, over 40,000 Canadians—roughly one every 12 minutes—and over 100 per day—die from sudden cardiac arrest.
Players in the worldwide automated external defibrillator market can benefit from attractive growth possibilities because of the increasing rate of cardiovascular diseases and the ageing population. The number of senior citizens is rising everywhere. Among those who are elderly, cardiovascular diseases (CVDs) are one of the most prevalent illnesses. For instance, as reported by WHO, 17.9 million people worldwide die from cardiovascular illnesses each year, making them the leading cause of mortality. Heart attacks and strokes account for more than four out of every five CVD fatalities, and one-third of these deaths happen before the age of 70.
The development of the worldwide market for automated external defibrillators is anticipated to be hampered by strict laws and regulations governing these devices and a lack of public awareness about sudden cardiac arrest. For instance, in order to guarantee the quality and dependability of AEDs, manufacturers in the United States are obliged to get premarket approval for all AEDs. The US FDA advises customers to confirm that their AED has FDA approval. The FDA’s strictest premarket submission requirement is premarket approval (PMA).
Coronavirus infection raises major concerns for people who have cardiac conditions. AEDs might be the difference between life and death for a person with an underlying cardiac problem as COVID-19 spreads. Due to government-ordered closures to stop the virus’s spread during the COVID-19 pandemic, the majority of AEDs were rendered inoperable. In summary, the current pandemic had two effects on the development of the market for automated external defibrillators.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/5078
The market for automated external defibrillators was valued at US$ 717.5 Mn in 2021 and is anticipated to grow at a CAGR of 7.8% from 2022 to 2028 to reach US$ 1,217.0 Mn.
Semi-automated external defibrillators, one of the analysis type segments, held the leading position in the global automated external defibrillator market in 2021, accounting for 71.3% share in terms of value; rising approval and the introduction of new products are anticipated to fuel the segment’s growth over the forecast period.
The automated external defibrillator market is anticipated to increase as a result of industry participants introducing innovative AEDs. n September 2019, Mindray declared the release of the BeneHeart C Series automated external defibrillator (AED), which operates more intelligently and delivers shocks more quickly for better resuscitation results in cases of unexpected cardiac arrest.
The market for automated external defibrillators is predicted to expand as people’s knowledge of heart health rises. For instance, the Casa Grande Fire Department, the Ak-Chin Indian Community, and the PulsePoint Foundation collaborated to run a registration campaign for nearby automated external defibrillators in May 2022 in recognition of National CPR Awareness Week (AEDs).
Shenzhen Mindray Bio-Medical Electronics Co. Ltd., ViVest Medical, BPL Medical Technologies Pvt. Ltd., Asahi Kasei Corporation, Mediana Co. Ltd., Stryker Corporation, CU Medical System Inc., Schiller AG, Koninklijke Philips, and Nihon Kohden Corporation are a few of the major companies active in the global automated external defibrillator market.
To gain a foothold in the Thai market, Zoll Medical announced the launch of 3 Automated External Defibrillator (AED) models in September 2021. This predicted an increase in Thailand’s AED demand to 10,000 units.
After receiving FDA premarket clearance for the device, Stryker released their Lifepak CR2 defibrillator with LifelinkCentral AED programme management in April 2019. The recently released Lifepak CR2 AED is equipped with cutting-edge technology, such as CPRInsight, which enables users to continue chest compressions while an ECG is being analysed and potentially increase survival rates.
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/5078
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Automated External Defibrillator Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Automated External Defibrillator Industry Impact
Chapter 2 Global Automated External Defibrillator Competition by Types, Applications, and Top Regions and Countries
2.1 Global Automated External Defibrillator (Volume and Value) by Type
2.3 Global Automated External Defibrillator (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Automated External Defibrillator Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Automated External Defibrillator Market Analysis
Chapter 6 East Asia Automated External Defibrillator Market Analysis
Chapter 7 Europe Automated External Defibrillator Market Analysis
Chapter 8 South Asia Automated External Defibrillator Market Analysis
Chapter 9 Southeast Asia Automated External Defibrillator Market Analysis
Chapter 10 Middle East Automated External Defibrillator Market Analysis
Chapter 11 Africa Automated External Defibrillator Market Analysis
Chapter 12 Oceania Automated External Defibrillator Market Analysis
Chapter 13 South America Automated External Defibrillator Market Analysis
Chapter 14 Company Profiles and Key Figures in Automated External Defibrillator Business
Chapter 15 Global Automated External Defibrillator Market Forecast (2022-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States
Phone: US +12067016702 / UK +4402081334027